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Abstract 
This study was carried out during the period (March to July 2012). A 
total of two hundred and fifty high vaginal swabs were collected from (100 
pregnant and 150 non- pregnant) women patients with genital tract infection 
at the age ranged between (18- 55) years, who attended the gynecology 
clinics and obstetrics department of Maternity Teaching Hospital in Erbil 
city. Vaginal swab samples were collected and direct examined for 
microscopic Gram stain examination and culture techniques. Isolated 
microorganisms were identified using microscopical, morphological, 
biochemical tests, analytic profile index system and also identification and 
sensitivity test were performed by Vitek 2 compact system. The results 
showed that positive vaginal cultures of Gram- negative bacteria isolates 
obtained from women patients were 73 isolates, which distributed among 
pregnant 20 (27.4%) and non- pregnant women 53 (72.6%) is not significant 
according to statistical analysis. All Gram negative bacterial (73) isolates 
were screened for their ability to produce extended spectrum β- lactamases 
enzymes by using double disk diffusion method. Out of 45 (61.6%) were 
found to be extended spectrum β- lactamases producers, which distributed 
among pregnant 9 (45%) and non- pregnant 36 (67.9%) but statistical 
analysis not significant. All Gram negative bacteria were screened for their 
ability to produce Ampicillin resistant gene (AmpC) β- lactamase enzyme by 
using Disk antagonism test. Out of (73) Gram negative bacteria isolates, 5 
(6.8%) were found to be AmpC β- lactamase producers. All Gram negative 
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bacteria were screened for their ability to produce metallo β- lactamase 
enzyme by using Imipenem- EDTA (Ethylene diamine tetra acetic acid) 
combined disc test. Out of (73) Gram negative bacteria isolates, 25 (34.2%) 
were found to be metallo β- lactamase producers, which distributed among 
pregnant 5 (25%) and non- pregnant 20 (37.7%). Among all Gram negative 
bacterial isolates were screened for their ability to produce (Extended 
spectrum β- lactamases, AmpC and metallo β- lactamase) enzymes and the 
results revealed that most of isolates produce more than one type of β- 
lactamase enzymes, for example all Escherichia coli isolates 30 (71.4%) 
were extended spectrum β- lactamases producers and 19 (45.2%) were 
metallo β- lactamase producers. 
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Introduction 
 Vaginitis is an infectious inflammation of the vaginal mucosa, which 
some times involves the vulva. This inflammation often causes itching, 
burning, irritation, discharge and discomfort.  It  is  one  of the most common 
reasons  for  women  to seek medical care (Egan and Lipsky, 1999).  
Vaginitis, whether infectious or not, poses one of the most common 
problems in gynaecology, and is one of the main reasons leading the females 
to seek advice from a physician approximately 10 million office visits 
annually (Syed and Braverman, 2004). 
 Several publications have also reported an altered vaginal microflora 
being linked to an increased susceptibility to other vaginal microorganisms 
include facultative anaerobes, coliforms, true anaerobes, and non- bacterial 
microorganism such as Candida albicans. Many of them are commensal; 
they live within this ecosystem but do not harm to the host (Alim et al., 
2009). 
 β- lactamases are enzymes produced by some bacteria that hydrolyze 
the β-lactam ring of β- lactam antibiotics (penicillins, ceohalosporins, 
monobactams, and carbapenems), is one of the most important mechanisms 
of microbial resistance to β- lactam antibiotics (Noyal et al., 2009). The 
hydrolyzed β-lactam drugs result in an inactive product when the ring is 
broken (Simoens et al., 2006).  
 One of the most important resistant mechanisms in Gram-negative 
bacteria against β- lactam antibiotics is induced by production of β- 
lactamase enzymes. Indeed, occurrence of point mutations in the sequence of 
the primary β- lactamase gene results in production of different enzymes. β- 
lactamase enzymes are classified into four main groups including A, B, C 
and D.  According  to  this  classification,  broad- spectrum β- lactamases are 
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categorized among group A. The Gram-negative bacteria have rapidly 
expanded resistance to broad- spectrum β- lactam antibiotics. More than 200 
types of extended- spectrum β- lactamases (ESBLs) have been found 
worldwide, most belonging to the Enterobacteriaceae family (Yazdi et al., 
2012). 
ESBL are bacterial enzymes that hydrolyse and confer resistance to 
modern cephalosporin antibiotics. They constitute the major mechanism of 
resistance to second, third and fourth generation cephalosporins for example: 
cefuroxime, cefotaxime, ceftriaxone and ceftazidime (Lavilla et al., 2008). 
Organisms often also possess resistance determinants to other antibiotic 
groups, such as aminoglycosides and fluoroquinolones, leaving an extremely 
limited range of effective agents (Weinbren and Borthwick, 2005).  
The ESBL producing E. coli are difficult to treat due to their 
resistance to wide spectrum of antibiotics including the third generation 
cephalosporine. Factors often responsible for Escherichia coli resistance 
include R-factor on plasmids, resistance genes on the chromosomes, 
production of β- lactamase and extended spectrum β-lactamase enzymes 
(Aboderin et al. ,2009).  
The prevalence of ESBL among clinical isolates varies among 
geographic areas with low rates of (3– 8%) in Sweden, Japan and Singapore 
to much higher prevalence rates reported from Portugal (34%), Latin 
America (30–60%), and Turkey 58% (Paterson and Bonomo, 2005).  
AmpC β- lactamases are Cephalosporinases which are poorly 
inhibited by Clavunic acid. They are differentiated from other ESBLs by 
their ability to hydrolyze Cephalosporins as well as other extended spectrum 
Cephalosporins (Manchanda and Singh, 2003).  
Several bacterial species Enterobacter spp., Citrobacter freundii, 
Pseudomonas spp., and Serratia marcescens have inducible chromosomally 
encoded AmpC cephalosporinase. Either inducibility or stable 
overproduction of this enzyme, resulting from mutation (Drieux et al., 2008).  
Many clinical laboratories currently test Escherichia coli and 
Klebsiella spp. for production of ESBLs but do not attempt to detect plasmid 
mediated AmpC β- lactamases (also known as imported, transmissible, 
foreign or mobile AmpC β- lactamases). These enzymes are typically 
associated with multiple antibiotic resistances (Black et al., 2005). It is 
important to know the occurrence of ESBL and AmpC producing strains as 
well as their antibiotic susceptibilities to newer agents to guide empirical 
therapy for various infections (Taneja et al., 2008).  
       ESBLs and AmpC β- lactamases are of increasing clinical concern. 
ESBLs are most commonly produced by Klebsiella spp. and E. coli but may 
also occur in other Gram- negative bacteria. They are typically plasmid 
mediated, clavulanate susceptible enzymes that hydrolyze penicillins, 
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expanded- spectrum cephalosporins (cefotaxime, ceftriaxone, ceftazidime, 
cefepime and others) and aztreonam (Moland et al., 2002).  
Carbapenems have been the most successful β- lactam antibiotics 
used in the treatment of infections caused by β- lactam resistant Gram- 
negative bacteria. The clinical utility of these antimicrobials is under threat 
with the emergence of carbapenemases, particularly the class B metallo β- 
lactamases (MBLs). MBLs can hydrolyze most β- lactams except for 
monobactams and confer a broad- spectrum β- lactam resistance to the 
bacterial host, which is not reversible by conventional therapeutic β- 
lactamase inhibitors. The prevalence of MBLs has been increasing 
worldwide, notably among Pseudomonas aeruginosa and lately, amongst 
other Gram- negative bacteria as well (Walsh et al., 2005). 
       MBLs producing Gram- negative bacteria an increasing public health 
problem worldwide because of their resistance to all β- lactams except 
aztreonam (Cornaglia et al., 2007). MBL genes are either carried transferable 
plasmids or are part of the bacterial chromosome (Walsh et al., 2005).  
 
Materials and Methods 
Samples collection: High vaginal swabs were collected from two 
hundred and fifty (250) women patients with vaginal symptoms who 
attended the gynecology clinics and obstetrics department of Maternity 
Teaching Hospital in Erbil city during the period from March to July 2012. 
All vaginal swabs were taken from married women patients, of these 100 
swabs from pregnant and 150 were from non-pregnant women. The age of 
these patients ranged between (18- 55) years.      
        High vaginal swabs were taken from women patients suffering with 
abnormal vaginal discharge, itching, burning and lower abdominal pain. The 
samples were taken from each women patient (by doctors) using sterile 
swabs stick and speculum. Vaginal swab for each patient were transported to 
the laboratory by inoculating the swab into a sterile tube containing 3 ml of 
normal saline. The samples were examined by staining with Gram stain was 
performed.   
Isolation of microorganisms: For isolation of microorganisms, the 
specimen of vaginal swab was directly inoculated on culture media: Blood 
agar, MacConkey agar at 37˚C for 24-48 (Oladele et al., 2011; Razzak et al., 
2011).   
Identification of microorganisms: Pure colonies of isolated 
microorganisms were identified using morphological, biochemical tests 
including API system (Forbes et al., 2002). Species identification and 
antibiograms for pathogens were performed using Vitek 2 compact system 
(Nagaraja, 2008). 
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Antimicrobial susceptibility testing: The susceptibility test was 
performed on 73 isolates belonging to different species of Gram negative 
bacteria by Vitek 2 compact system  to different antibiotics (31) are 
represented in table (3), and also by Disc diffusion method, also known as 
the Kirby- Bauer method was carried out according to the Clinical and 
Laboratory Standard Institute guidelines (CLSI), formerly the National 
Committee for Clinical Laboratory Standards (NCCLS) (Wayne, 2005) were 
performed against 30 antibiotics. 
 
Detection of β- lactamase in Gram negative bacteria  
A total of 73 samples isolates of Gram negative bacteria were 
screened for different type of β- lactamase enzyme which were responsible 
for resistant mechanisms in Gram negative bacteria.  
 
Detection of extend spectrum β- lactamase (ESBL)  
Confirmatory test for detection of ESBL by double disc diffusion 
test: Extend spectrum β- lactamases (ESBLs) are plasmid– mediated 
enzymes produced by a number of Gram negative bacteria (Collins et al., 
2004). A double disc diffusion test was performed with amoxicillin- 
clavulanic acid surrounded by aztreonam and third generation cephalosporin 
discs cefotaxime and ceftazidime (Freitas et al., 2003). 
 
Detection of AmpC β- lactamase  
Confirmatory test for detection of AmpC enzymes by disk 
antagonism test: Tested isolates with a turbidity equivalent to that of 0.5 
McFarland standards was spread over a Muller Hinton agar plate. 
Cefotaxime (30µg/ml) and Cefoxitin (30µg/ml) disks were placed 20 mm 
apart from center to center, after overnight incubation an isolates showing 
blunting of the cefotaxime zone of inhibition adjacent to the cefoxitin disk or 
reduced susceptibility to each of them were screened as positive for AmpC 
β-lactamase production (Smatha and Parveen, 2011). 
 
Detection of metallo β- lactamase:  
Imipenem (IMP) - EDTA combined disc test: The IMP- EDTA 
combined disk test was performed by the test organisms were inoculated on 
to plates with Muller Hinton agar as recommended by the CLSI (Institute, 
2006). Two (10µg/ml) imipenem disks were placed on the plate, and 
appropriate amounts of 10µl of EDTA solution were added to one of them to 
obtain the desired concentration (750µg/ml). The inhibition zones of the 
imipenem and imipenem- EDTA disks were compared after 18- 24 hours of 
incubation at 37˚C. In the combined disc test, if the increase in inhibition 
zone with the Imipenem and EDTA disc was > 7 mm than the Imipenem disc 
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alone, it was considered as Metallo β- lactamase positive (Behera et al., 
2008). 
Solution of a 0.5 M (Molarity) EDTA was prepared by dissolving 
186.1 gm of EDTA. 2H2O in 1000 ml of distilled water and its pH was 
adjusted to 8.0 by using NaOH and sterilized by autoclaving (Yong et al., 
2002). 
 
Results and discussion 
A total of two hundred and fifty (250) high vaginal swabs were 
collected from women patients attending Maternity Teaching Hospital in 
Erbil city suspected of having vaginitis (We exclude the patients who are 
unmarried). The results of this study indicated that 73 (38.2%) of Gram- 
negative bacteria with vaginitis detected in pregnant and non- pregnant 
women with symptoms as illustrated in table (1). The statistical analysis 
showed no significant differences of infection among non- pregnant and 
pregnant. Statistical difference were determined by Chi- square (X2) test. 
Probability value (P-value) less than (< 0.05) was considered as statistically 
significant (*), while P-value more than (> 0.05) was considered as 
statistically not significant. 
This result in agreement with those dictated by Razzak et al., (2011) 
in Babylon (Iraq) showed that (44.8%) samples gave positive culture for 
Gram- negative bacteria, and agree with Al- Muk and Hansony (2001) from 
Basrah (Iraq), they reported in pregnant women the rate of Gram- negative 
bacteria were (13.5%), and agree with Saini et al., (2003) from India, he 
reported the Gram- negative bacteria (47.4%). 
The results also showed that the percentage of positive culture in 
pregnant women 20 (30.3%) were higher than non- pregnant women 53 
(42.2%), but statistically not significant difference. Our results seem to agree 
with finding by Jarjees (2006) from Erbil (Iraq) who reported in pregnant 
(71%) and in non- pregnant (67%). The high incidence of infection in 
pregnant women could be attributed to hormonal changes (Greeenwood et 
al., 2002). 
The presence of this bacteria in large percent in urinary tract and 
bacterial vaginosis might be attributed to the fact that this bacteria is part of 
the normal fecal flora and different virulence factors contributing to their 
pathogenicity and the difference in the result might be attributed to the 
number of sample taken and the difference in the time (year) of the study.         
The most common Gram negative bacteria isolated from the vaginal 
women with vaginitis was Escherichia coli 42 (57.5%), also the frequency of 
Escherichia coli in non- pregnant 30 (56.6%) higher compared to pregnant 
12 (60%) are showed in table (2). These results were agreement with those 
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reported in our country such as by Jarjees (2006) from Erbil (Iraq) in non-
pregnant (53.2%) and in pregnant (48.6%).  
The low frequency of infection noticed by Pseudomonas aeruginosa 
was 2 (2.7%) and Pseudomonas luteola was 1 (1.4%). Similar findings were 
obtained by  Al- Jammaly and Abdulla (2008) from Mosul (Iraq) (1.9%) and 
Mumtaz et al., (2008) from Pakistan (1.8%), they reported that the incidence 
of infection with Pseudomonas aeruginosa.  
In the present study the antimicrobial susceptibility test done by 
Vitek 2 compact system, The result showed that in table (3) among Gram- 
negative bacteria the most effective antibiotics that have low percentage of 
resistance were Meropenem (0%) but for Imipenem was 5 (6.8%) and 
Amikacin was 9 (12.3%) when used for all tested Gram- negative bacteria. 
While the isolates showed high percentage of resistance to Ampicillin 65 
(89%), followed by Amoxicillin/ clavunic acid 41 (56.2%), Aztreonam and 
Clindamycin 39 (53.4%) for each. 
       Similar finding have been obtained by Jarjees (2006) from Erbil 
(Iraq) who reported that the percentage of resistance to Imipenen (13%) and 
Amikacin (10%), while the high resistance to  Penicillin (89%), Amipicillin 
(79.5%) and Tetracycline (72.5%) among gram positive and negative 
bacterial isolated from genitourinary tract infection. Oladele et al., (2011) 
from Nigeria reported the incidence of antibiotic resistance among bacterial 
isolated from vaginitis were Amoxicillin/ clavunic acid (60%), Amipicillin 
(60%), Tetracycline (40%). 
       Extended spectrum β- lactamases (ESBLs) are usually inhibited by β- 
lactamase inhibitors, such as clavulanic acid, sulbactam or tazobactam. 
Therefore, use of β- lactam/ β- lactamase inhibitor combinations has been 
considered for the treatment of infections due to ESBL- producing 
organisms. In addition, increased use of carbapenems to treat ESBL- 
producing organisms has been associated with the emergence of 
carbapenem- resistant organisms (Rupp and Fey, 2003).   
       The result represent ESBL production occurred in 45 (61.6%) out of 
(73) Gram- negative bacteria isolates as seen in table (4) an figure (1), with 
highest incidence in Enterobacter aerogenes, Serratia fonticola, Raoultella 
ornithinolytica, Pantoea agglomerans and Sphingomonas paucimobilis 
(100%) for each, followed by E. coli 30 (71.4%), Klebsiella pneumoniae 7 
(50%), Proteus mirabilis 2 (40%). When comparing the result to other study 
we notice similar finding have been obtained by Al- Haidari (2010) from 
Erbil (Iraq) who found that (76.3%) of Gram- negative bacteria isolates were 
ESBL producer and showed that ESBL production ranged among E. coli  
(77.1%), Proteus mirabilis (42.9%) and Enterobacter spp. (100%). Al- 
Nammi (2001) in Baghdad (Iraq), who reported that (72.6%) of E. coli  
isolates gave positive ESBL.  
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       But different results have been obtained by Jarjees (2006) from Erbil 
(Iraq) who reported that ESBL production by BV ranged among E. coli 
(86.07%), Proteus mirabilis (55.55%), Klebsiella pneumoniae (80%) and 
Enterobacter aerogenes (60%). Al- Zarouni et al., (2008) in Unit Arab 
Emirates, who found that the ESBL production in E. coli (39%), Klebsiella 
pneumoniae (42%). Yasushisa (1994) from Japan who found that the 
production of ESBL enzymes were (84.7%) in E. coli and (65.4%) in 
Klebsiella pneumoniae.             
       Many clinical microbiological laboratories still face significant 
problems with ESBL screening and identification as ESBL pathogens can 
present with variations in the in vitro pattern of resistance to β- lactam 
agents. Proficiency-testing studies performed by the World Health 
Organization and the Centers for Disease Control have raised concerns about 
the current ability of many clinical laboratories to detect ESBL-producing 
microorganisms (Hageman et al., 2003).  
On the other hand the results in the present study also showed that out 
of (73) Gram- negative bacteria only 5 (6.8%) isolates were produce AmpC 
β- lactamase as shown in figure (2), showed that AmpC β- lactamase 
production ranged  among Pseudomonas luteola and Ewingella americana 1 
(100%) each, followed by Pseudomonas aeruginosa 1 (50%) and Proteus 
mirabilis 2 (40%). Similar results were reported by Sanguinetti et al., (2003) 
from Italy reported (11.6%) AmpC β- lactamase positive among Gram- 
negative bacteria isolates. 
Other result reported by  Samatha and Praveen (2011) from India 
who showed that among gram negative bacteria (24.6%) screen positive to 
AmpC, which include Pseudomonas spp. (33.3%) and Proteus spp. (16.7%) 
were screen positive to AmpC. 
       Among the β- lactamases the production of  ESBLs  and  AmpC β-
lactamases are the most common mechanisms for resistance to β- lactam 
antibiotics in Gram negative bacteria (Taneja et al., 2008). 
Carbapenems have a broad spectrum of antibacterial activity and 
these are resistant to hydrolysis by most β- lactamases including ESBLs and 
AmpC β-lactamases. These are often used as a last resort in infections due to 
multi drug resistant Gram- negative bacilli (Noyal et al., 2009). 
        Furthermore the results in the present study showed that out of (73) 
Gram negative bacteria tested 25 (34.2%) isolates were produce metallo β- 
lactamase as seen in figure (3), They were distributed among E. coli 19 
(45.2%), Klebsiella pneumoniae 5 (35.7%) and Sphingomonas paucimobilis 
1 (100%). Similar results were reported by Enwuru et al., (2011) from 
Nigeria reported that among Gram- negative bacterial strains tested (23%) 
were confirmed to be MBL producer, in this E. coli (50%) and Klebsiella 
spp. (36%). 
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       MBLs producing Gram-negative bacteria are an increasing public 
health problem world wide because of their resistance to all β- lactam except 
Aztreonam. MBL genes are typically carried on transferable plasmids or are 
part of the bacterial chromosome. This enzyme which have been detected 
primarily in Pseudomonas aeruginosa but were also found in other Gram-
negative bacteria, including nonfermenters and members of the family 
Enterobacteriaceae (Valenza et al., 2010).  
       The awareness of the existence of MBL initializes indication for the 
need for proper use of antibiotics and spread of multi drug resistance 
bacterial strains within these hospital and communities. 
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Table (1): Distribution of Gram- positive and Gram- negative bacteria in relation to 
pregnant and non- pregnant women with vaginitis 
Bacterial vaginosis Non- pregnant Pregnant Total 
No. % No. % No. % 
Gram- positive bacteria 72 57.6 % 46 69.7 % 118 61.8 % 
Gram- negative bacteria 53 42.4 % 20 30.3 % 73 38.2 % 
Total 125 65.4 % 66 34.6 % 191 100 % 
Chi- square (x2) 2.68   N.S. 
Note: N.S. = No Significant 
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Table (3): Distribution of Gram- negative bacteria in vaginitis in relation to pregnant 
and non- pregnant women 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Isolated Gram- negative 
bacteria 
Non- pregnant Pregnant Total 
No. % No. % No. % 
Escherichia  coli 30 56.6 % 12 60 % 42 57.5 % 
Klebsiella  pneumoniae 12 22 .6% 2 10 % 14 19.1 % 
Proteus  mirabilis 3 5.6 % 2 10 % 5 6.8 % 
Pseudomonas  aeruginosa 2 3.8 % 0 0 % 2 2.7 % 
Pseudomonas  luteola 1 1.9 % 0 0 % 1 1.4 % 
Serratia  fonticola 1 1.9 % 1 5 % 2 2.7 % 
Serratia  plymuthica 1 1.9 % 0 0 % 1 1.4 % 
Enterobacter  aerogenes 0 0 % 1 5 % 1 1.4 % 
Acinetobacter  lwoffii 1 1.9 % 0 0 % 1 1.4 % 
Raoultella  ornithinolytica 1 1.9 % 0 0 % 1 1.4 % 
Pantoea  agglomerans 0 0 % 1 5 % 1 1.4 % 
Sphingomonas  paucimobilis 0 0 % 1 5 % 1 1.4 % 
Ewingella  americana 1 1.9 % 0 0 % 1 1.4 % 
Total 53 72.6 % 20 27.4 % 73 100 % 
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Table (4): The number and percentage of antibiotics resistance in Gram negative bacteria 
Total No. of isolated 
bacteria 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
AMP AX AMC AK ATZ CIP CD CX CRO CTX CAZ CEFE COT CEFL CEFP 
Escherichia  coli 
(42) 
40 
95.2% 
* 
 
26 
61.9
% 
7 
16.7
% 
25 
59.5% 
14 
33.3% 
20 
47.6% 
5 
11.9% 
20 
47.6% 
21 
50% 
23 
54.8% 
15 
35.7% 
8 
19% 
2 
4.8% 
9 
21.4
% 
Klebsiella  
pneumoniae  (14) 
14 
100% 
* 
 
8 
57.1
% 
1 
7.1% 
7 
50% 
5 
35.7% 
6 
42.9% 
1 
7.1% 
6 
42.9% 
7 
50% 
6 
42.9% 
3 
21.4% 
1 
7.1% 
2 
14.3% 
2 
14.3
% 
Proteus  mirabilis 
(5) 
5 
100% 
* 
 
3 
60% 
0 0 2 
40% 
5 
100% 
0 * 2 
40% 
2 
40% 
* * 
 
2 
40% 
* 
Pseudomonas  
aeruginosa  (2) 
2 
100% 
* 
 
2 
100% 
0 0 0 2 
100% 
2 
100% 
2 
100% 
2 
100% 
0 0 * 
 
1 
50% 
1 
50% 
Pseudomonas  luteola  
(1) 
1 
1005 
* 
 
0 0 1 
100% 
0 1 
100% 
1 
100% 
0 0 0 0 * 
 
0 0 
Serratia  fonticola (2) 1 
50% 
0 
 
0 0 2 
100% 
1 
50% 
1 
50% 
0 1 
50% 
2 
100% 
0 0 * 
 
* 0 
Serratia  plymuthica  
(1) 
0 0 
 
0 0 0 0 0 0 0 0 1 
100% 
0 * 
 
* 0 
Enterobacter  
aerogenes  (1) 
1 
100% 
* 
 
1 
100% 
0 1 
100% 
0 1 
100% 
1 
100% 
1 
100% 
1 
100% 
0 0 * 
 
1 
100% 
* 
Acinetobacter  lwoffii  
(1) 
0 * 
 
0 0 0 0 0 0 0 0 0 0 * 
 
1 
100% 
0 
Raoultella  
ornithinolytica (1) 
1 
100% 
* 
 
0 0 1 
100% 
1 
100% 
1 
100% 
1 
100% 
1 
100% 
1 
100% 
0 0 * 
 
* * 
Pantoea  
agglomerans  (1) 
0 * 
 
0 0 1 
100% 
0 0 0 * 0 0 0 * 
 
* * 
Sphingomonas  
paucimobilis  (1) 
0 * 
 
0 1 
100% 
1 
100% 
0 1 
100% 
1 
100% 
0 0 0 0 * 
 
* * 
Ewingella  americana  
(1) 
0 1 
100% 
1 
100% 
0 0 0 1 
100% 
0 0 0 0 1 
100% 
* 
 
* * 
Total No. 73 & % in 
total of antibiotic 
used 
65 
89% 
1 
0.25
% 
41 
56.2
% 
9 
12.3
% 
39 
53.4% 
23 
31.5% 
39 
53.4% 
12 
16.4% 
31 
46.3% 
36 
49.3 
32 
43.8% 
19 
28% 
9 
16.1
% 
9 
13.6% 
12 
19% 
* These antibiotics were not used (not done);  AMP (Ampicillin), AX (Amoxicillin), AMC (Amoxicillin clavunic acid), AK (Amikacin), ATZ 
(Aztreonam), CIP (Ciprofloxacin), CD (Clindamycin), CX (Cefoxitin), CRO (Ceftriaxone), CTX (Cefotaxime), CAZ (Ceftazidime), CEFE 
(Cefepime),  COT (Co- trimidazole), CEFL (Cefalotin), CEFP (Cefpodoxime). 
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Total No. of isolated 
bacteria 
16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 
CEFU CEFA E GEN IMP NIF NOR NA PIP VA RA TOB TE ME
R 
TCC TRIM 
Escherichia  coli 
(42) 
10 
23.8% 
20 
47.6% 
16 
38.1% 
13 
31% 
1 
2.3% 
4 
9.5% 
* 6 
14.3% 
9 
21.4% 
16 
38.1
% 
16 
38.1% 
6 
14.3% 
15 
35.7% 
0 13 
31% 
16 
38.1% 
Klebsiella  pneumoniae  
(14) 
2 
14.3% 
4 
28.9% 
6 
42.9% 
4 
28.9% 
0 8 
57.1% 
* 2 
14.3% 
4 
28.9% 
6 
42.9
% 
6 
42.9% 
3 
21.4% 
5 
35.7% 
0 * 4 
28.9 
Proteus  mirabilis  (5) 2 
40% 
* 
 
* 3 
60% 
2 
40% 
5 
100% 
2 
40% 
* 0 * * 0 5 
100% 
0 * 5 
100% 
Pseudomonas  aeruginosa  
(2) 
1 
50% 
2 
100% 
* 0 0 2 
100% 
0 * 0 * 0 0 2 
100% 
* * 2 
100% 
Pseudomonas  luteola  (1) 0 0 
 
* 0 0 1 
100% 
0 * 0 * 0 0 0 * * 1 
100% 
Serratia  fonticola  (2) * 1 
50% 
* 0 0 0 0 * 0 * * 1 
50% 
0 * * 0 
Serratia  plymuthica  (1) * 1 
100% 
* 0 0 0 0 * 0 * * 0 0 * * 1 
100% 
Enterobacter  aerogenes  
(1) 
* 1 
100% 
* 1 
100% 
0 0 0 * 0 * * 1 
100% 
0 0 * 1 
100% 
Acinetobacter  lwoffii  (1) 0 0 
 
* 0 0 1 
100% 
0 * 0 * * 0 0 0 * 0 
Raoultella  ornithinolytica                          
(1) 
1 
100% 
1 
100% 
* 1 
100% 
1 
100% 
1 
100% 
1 
100% 
* 0 * * 1 
100% 
1 
100% 
* * 1 
100% 
Pantoea  agglomerans  (1) 0 0 
 
* 0 0 0 0 * 0 * * * 0 * * 0 
Sphingomonas  
paucimobilis  (1) 
0 0 
 
* 0 0 0 0 * 0 * * * 0 * * 0 
Ewingella  americana  (1) * * 
 
* 1 
100% 
1 
100% 
1 
100% 
1 
100% 
* 0 * * 1 
100% 
1 
100% 
* 0 1 
100% 
Total No. 73 & % in total 
of antibiotic used 
16 
23.5% 
30 
44.8% 
22 
39.3% 
23 
31.5% 
5 
6.8% 
23 
31.5% 
4 
23.5% 
8 
14.3% 
13 
17.8% 
22 
39.3
% 
22 
37.3% 
13 
18.3% 
29 
39.7% 
0 
0% 
13 
30.2% 
32 
43.8% 
CEFU (Cefuroxime), CEFA (Cefazolin), E (Erythromycin), GEN(Gentamicin), IMP (Imipenem), NIF (Nitrofurantoin), NOR (Norfloxacin), NA 
(Nalidixic acid), PIP (Piperacillin), VA (Vancomycin), TOB (Tobromycin), RA (Rifampicin), TE (Tetracycline), TRIM (Trimethoprim), TCC 
(Ticarcillin clavunic acid), MER (Meropenem), 
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Table (5): Frequency of ESBL and AmpC β- lactamase and metallo β-lactamase 
producing Gram- negative bacteria 
 
 
Gram- negative bacteria 
isolated 
Total 
No.  of 
isolated 
No. &  % of 
isolated with ESBL 
No. &  % of 
isolated with AmpC 
β- lactamase 
No. &  % of 
isolated with  
Metallo β- 
lactamase 
Positive Negative Positive Negative Positive Negative 
Escherichia  coli 42 30 
(71.4%
) 
12 
(28.6%) 
0 
(0 %) 
42 
(100%) 
19 
(45.2%
) 
23 
(54.8%) 
Klebsiella  pneumoniae 14 7 
(50%) 
7 
(50%) 
0 
(0 %) 
14 
(100%) 
5 
(35.7%
) 
9 
(64.3%) 
Proteus  mirabilis 5 2 
(40%) 
3 
(60%) 
2 
(40 %) 
3 
(60%) 
0 
(0 %) 
5 
(100%) 
Pseudomonas  
aeruginosa 
2 0 
(0 %) 
2 
(100%) 
1 
(50%) 
1 
(50%) 
0 
(0 %) 
2 
(100%) 
Pseudomonas  luteola 1 0 
(0 %) 
1 
(100%) 
1 
(100%) 
0 
(0 %) 
0 
(0 %) 
1 
(100%) 
Serratia  fonticola 2 2 
(100%) 
0 
(0 %) 
0 
(0%) 
2 
(100%) 
0 
(0 %) 
2 
(100%) 
Serratia  plymuthica 1 0 
(0 %) 
1 
(100%) 
0 
(0 %) 
1 (100%) 0 
(0 %) 
1 
(100%) 
Enterobacter  
aerogenes 
1 1 
(100%) 
0 
(0 %) 
0 
(0 %) 
1 (100%) 0 
(0 %) 
1 
(100%) 
Acinetobacter  lwoffii 1 0 
(0 %) 
1 
(100%) 
0 
(0 %) 
1 (100%) 0 
(0 %) 
1 
(100%) 
Raoultella  
ornithinolytica 
1 1 
(100%) 
0 
(0 %) 
0 
(0 %) 
1 (100%) 0 
(0 %) 
1 
(100%) 
Pantoea  agglomerans 1 1 
(100%) 
0 
(0 %) 
0 
(0%) 
1 (100%) 0 
(0 %) 
1 
(100%) 
Sphingomonas  
paucimobilis 
1 1 
(100%) 
0 
(0 %) 
0 
(0 %) 
1 (100%) 1 
(100%) 
0 
(0 %) 
Ewingella  americana 1 0 
(0 %) 
1 
(100%) 
1 
(100%) 
0 
(0 %) 
0 
(0 %) 
1 
(100%) 
 
Total 
 
 
73 
 
45    
(61.6%
) 
 
28    
(38.4%) 
 
5     
(6.8%) 
 
68    
(93.2%) 
 
25    
(34.2%
) 
 
48      
(65.8%) 
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                           A                                                             B 
Figure (1): Double- disk diffusion test used for the detection of ESBL production in 
Gram negative bacteria; (A) ESBL negative, (B) ESBL positive 
 
                            
A                                                           B 
Figure (2): Disk antagonism test used for the detection of AmpC β- lactamase 
production in Gram negative bacteria; (A) AmpC β- lactamase negative (Absence of 
blunting indicates negative), (B) AmpC β- lactamase positive (Blunting of the 
cefotaxime disc adjacent to the cefoxitin disk, positive) 
 
 
                       A                                                       B 
Figure (3): Imipenem (IMP)- EDTA combined disc test used for the detection of 
metallo β- lactamase production in Gram negative bacteria; (A) Metallo β- lactamase 
negative,  (B) Metallo β- lactamase positive (IMP- EDTA increase clear zone of 
inhibition). 
